Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SOAR Bio is a therapeutics-focused biotech venture studio based in the Greater Washington region. The company builds new biotech companies from scratch by pairing experienced entrepreneurs with scientific fellows and translating regional discoveries into commercial therapies. Its operating model emphasizes seed-stage company creation, internal program optimization, translational development, and rapid advancement of promising assets. SOAR Bio states that it has in-house capabilities spanning intellectual property, preclinical development, regulatory, manufacturing, quality, translational science, clinical operations, strategy, and marketing. Rather than marketing a disclosed clinical pipeline, it appears to function primarily as a company-creation and therapeutic incubation platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SOAR.